PARP inhibitor era: current status and future directions
- PMID: 36958753
- DOI: 10.1136/ijgc-2023-004464
PARP inhibitor era: current status and future directions
Keywords: Ovarian Cancer.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer: lessons learned and future directions.Int J Gynecol Cancer. 2023 Apr 3;33(4):431-443. doi: 10.1136/ijgc-2022-004149. Int J Gynecol Cancer. 2023. PMID: 36928097 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
